메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

FDA 510(k) Clearance Establishes Broad Intended Use for Copan's PhenoMATRIX®, Expanding Clinical Microbiology Capabilities

MURRIETA, Calif., Feb. 17, 2026 -- Copan Group announced today that PhenoMATRIX®, its automated image assessment software used with WASPLab® full laboratory automation, received FDA 510(k) clearance as a Class II device in the United States. PhenoMATRIX is an in vitro diagnostic software that uses artificial intelligence with laboratory-defined rules and clinical information to automatically sort images of bacterial culture plates, helping laboratory professionals streamline plate review while maintaining expert oversight. The cleared intended use include
- 김갑성 기자
- 2026-02-17 23:00
코판의 PhenoMATRIX®, FDA 510(k) 승인으로 광범위한 사용 목적 확립 및 임상 미생물학 역량 확대

무리에타, 캘리포니아, 2026년 2월 17일 -- 2월 17일 코판 그룹(Copan Group)이 자사의 전면 검사실 자동화 솔루션인 WASPLab®과 함께 사용되는 자동 이미지 판독 소프트웨어 PhenoMATRIX®가 미국에서 2등급 의료기기로 FDA 510(k) 승인을 획득했다고 발표했다. PhenoMATRIX는 인공지능(AI)과 검사실에서 정의한 규칙 및 임상 정보를 결합해 세균 배양 플레이트 이미지를 자동으로 분류하는 체외 진단 소프트웨어로, 검사실 전문가는 이 소프트웨어를 활용해 전문적 감독을 유지하면서 효율적으로 플레이트를 판독할 수 있다. 이번에 승인된 사용 목적에는 혈액 한천, 초콜릿 한천, 맥콘키 한천(MacConkey agar) 및 CHROMagar orientation 배양 배지 플레이트가 포함된다. 이를 통해 미생물 성장 감지, 집락 수 추정, 표현형 집락 특성에 따른 분리균 감별을 통해 반정량적 및 정성적 이미지 기반 분석을 수행할 수 있다. 코판 다이애그노스틱스(Copan Diagnostics)의 파브리치오 마조키(Fabrizio Mazzocchi)
- 김갑성 기자
- 2026-02-17 23:00
In the Age of AI, Animal Fables and Editorial Cartoons Return

NEW YORK, Feb. 17, 2026 -- As artificial intelligence reshapes the 21st century, Student B Press has launched Animal Intelligence, a cross-genre publishing project that revives animal fables and editorial cartoons as tools for reflection in the AI era. Throughout history, moments of technological and social upheaval have given rise to allegory and satire—forms that return when language struggles to keep pace with change. Animal Intelligence reimagines these traditions through a contemporary publishing universe that blends philosophical fables and cartoons. Observing Huma
- 김장윤(JASON KIM) 기자
- 2026-02-17 22:30
NYSE Content Update: USA TODAY Co. Rings Opening Bell to Celebrate Rebrand

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 17, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. USA TODAY Co. Celebrates Its Rebrand at NYSE Ashley Mastronardi delivers the pre-market update on February 17th Stocks are down Tuesday morning ahead of a shortened trading week after markets were closed yesterday for Presidents Day. Leaders from Payments platfor
- 황정호 기자
- 2026-02-17 22:05
BON Partners with Chang'an Pilot to Launch World-Class Joint Laboratory for Natural Ingredient Bio-manufacturing

XI'AN, China, Feb. 17, 2026 -- Bon Natural Life Limited (Nasdaq: BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, today announced the establishment of the BON & Pilot Joint Laboratory for Natural Ingredients and Bio-Manufacturing (the "Joint Laboratory"). The Joint Laboratory was inaugurated on December 18, 2025 through a collaboration between the Company's domestic operating subsidiary, Xi'an App-Chem Bio-Tech Co., Ltd., and Shaanxi Chang'an Pilot Life Science Industry Innovation Center Co.,
- 김갑성 기자
- 2026-02-17 22:00
Aon Joins Ferrari Hypersail as Premium Partner

[ 메디채널 황정호 기자 ] Aon Expands Ferrari Partnership into High-Performance Sailing, Promoting Innovation and Resilience MILAN, Feb. 17, 2026 -- Aon plc (NYSE: AON), a leading global professional services firm, today announced that it will serve as the Premium Partner of Ferrari Hypersail, an unprecedented marine initiative dedicated to high-performance sailing. In 2025, Aon became an Official Partner of the Scuderia Ferrari HP Formula One team through a multi-year agreement. By extending their relationship from the racetrack to the water, Aon aims to demonstrate how resilience and
- 황정호 기자
- 2026-02-17 22:00
Metabolon's Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity

Metabolomics-Derived Pathway Scores Outperform Inflammatory Protein Markers—Delivering Risk Prediction Where Proteomics Falls Short MORRISVILLE, N.C., Feb. 17, 2026 -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced its industry-leading global metabolomics platform was used by researchers from Kite, a Gilead company, for the most extensive metabolomic study ever conducted in the context of CAR T-cell therapy. Leverag
- 김갑성 기자
- 2026-02-17 22:00
Nature's Miracle Holding Inc. Begins Offering Made-in-USA Grow Lights Through Exclusive Agreement with Megaphoton USA LLC

ONTARIO, Calif., Feb. 17, 2026 -- Nature's Miracle Holding Inc. ("Nature's Miracle," "NMHI," or the "Company"), a provider of equipment and services for the controlled environment agriculture (CEA) industry, today announced it has signed an exclusive supply agreement with Megaphoton USA LLC, a Los Angeles-based specialized manufacturer of grow lights. This strategic partnership strengthens Nature's Miracle's domestic supply chain capabilities while addressing growing customer demand for reliable, U.S.-manufactured CEA lighting solutions.
- 황정호 기자
- 2026-02-17 21:30
Asia Bankers Club Appoints Ian Banerjee as Managing Director, Launches Global Office in Dubai

DUBAI, UAE, Feb. 17, 2026 -- Asia Bankers Club has appointed Ian Banerjee as Managing Director, coinciding with the opening of its Dubai Global Office, as the group speeds up its expansion and further embeds its presence in the Middle East. The Dubai Global Office will be a key connectivity hub between the west and the east with a particular emphasis on facilitating investment, entrepreneurship, and business setup and market entry across the region. Ian has global leadership experience in entrepreneurship, alternative assets, and the cruise and maritime real estate indus
- 황정호 기자
- 2026-02-17 21:30
Marvion Inc. Announces Two New Investors, Further Strengthening Capital Base and Advancing Strategic Growth

HONG KONG, Feb. 17, 2026 -- Marvion Inc. (OTCQB: MVNC) (the "Company" or "Marvion") today announced that on February 2, 2026, the Company entered into Stock Purchase Agreements with two new investors. The transactions were duly disclosed through a Form 8-K filing in accordance with applicable regulations. The addition of these new investors reflects continued market recognition of Marvion's strategic direction and long-term growth potential. The new capital further strengthens the Company's financial foundation and provides additional flexibility to support business
- 황정호 기자
- 2026-02-17 21:18

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 02일 17시 20분